- Home
- ZLAB vs CXT Comparison
ZLAB vs CXT Comparison
Compare ZLAB & CXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZLAB
- CXT
- Stock Information
- Founded
- ZLAB 2013
- CXT 1855
- Country
- ZLAB China
- CXT United States
- Employees
- ZLAB N/A
- CXT N/A
- Industry
- ZLAB Biotechnology: Pharmaceutical Preparations
- CXT Office Equipment/Supplies/Services
- Sector
- ZLAB Health Care
- CXT Industrials
- Exchange
- ZLAB Nasdaq
- CXT Nasdaq
- Market Cap
- ZLAB 3.0B
- CXT 3.3B
- IPO Year
- ZLAB 2017
- CXT N/A
- Fundamental
- Price
- ZLAB $26.67
- CXT $55.40
- Analyst Decision
- ZLAB Strong Buy
- CXT Strong Buy
- Analyst Count
- ZLAB 4
- CXT 3
- Target Price
- ZLAB $52.50
- CXT $87.67
- AVG Volume (30 Days)
- ZLAB 1.1M
- CXT 367.8K
- Earning Date
- ZLAB 11-12-2024
- CXT 11-06-2024
- Dividend Yield
- ZLAB N/A
- CXT 1.17%
- EPS Growth
- ZLAB N/A
- CXT N/A
- EPS
- ZLAB N/A
- CXT 3.05
- Revenue
- ZLAB $355,748,000.00
- CXT $1,444,600,000.00
- Revenue This Year
- ZLAB $48.50
- CXT $8.03
- Revenue Next Year
- ZLAB $47.37
- CXT $3.86
- P/E Ratio
- ZLAB N/A
- CXT $17.99
- Revenue Growth
- ZLAB 35.01
- CXT 5.25
- 52 Week Low
- ZLAB $13.48
- CXT $50.31
- 52 Week High
- ZLAB $36.60
- CXT $64.80
- Technical
- Relative Strength Index (RSI)
- ZLAB 41.98
- CXT 47.96
- Support Level
- ZLAB $27.74
- CXT $55.36
- Resistance Level
- ZLAB $32.15
- CXT $57.23
- Average True Range (ATR)
- ZLAB 1.36
- CXT 1.25
- MACD
- ZLAB -0.64
- CXT 0.11
- Stochastic Oscillator
- ZLAB 3.15
- CXT 47.63
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-2306 for treatments across multiple solid tumor types including ovarian and certain types of breast and lung cancers; ZL-2401 which is an antibiotic in a new class of tetracycline derivatives; and ZL-2301 is an oral, small molecule which targets HCC.
About CXT Crane NXT Co.
Crane NXT Co is a industrial technology company that provides proprietary and trusted technology solutions to secure, detect, and authenticate what matters to its customers. It is a pioneer in proprietary micro-optics technology for securing physical products, and its sophisticated electronic equipment and associated software leverages proprietary core capabilities with detection and sensing technologies. The company operates in two segments which are Crane Payment Innovations (CPI) and Crane Currency.